1. Robert P: Worldwide supply and demand of plasma and plasma-derived medicines. Iran J Blood Cancer. 2011, 3: 111-120.
2. Burnouf T: Plasma fractionation in Asia–Pacific: challenges and perspectives. ISBT Sci Series. 2011, 6: 366-372. 10.1111/j.1751-2824.2011.01517.x.
3. Farrugia A, Cassar J: Plasma derived medicines: access and usage issues. Blood Transfus. 2012, 10: 273-8.
4. World Federation of Hemophilia: World Federation of Hemophilia Report on the Annual Global Survey. 2010,
http://www1.wfh.org/publications/files/pdf-1427.pdf
,
5. European Reference Paper: Primary Immunodeficiencies (PID) Driving Diagnosis for Optimal Care in Europe. Primary Immunodeficiencies (PID) Driving Diagnosis for Optimal Care in Europe. 2010, Available at:
http://www.info4pi.org/Documents/Publications/Primary_Immunodeficiencies_%28PID%29_European_Reference_Paper_2010_20100705_104140.pdf
,